Small molecule drug with a maximum clinical stage of Approval (across all indications), with 11 approved and 2 investigational indications.
targets
Histamine H1 receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that